Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

E4 ligase-specific ubiquitination hubs coordinate DNA double-strand-break repair and apoptosis.

Ackermann L, Schell M, Pokrzywa W, Kevei É, Gartner A, Schumacher B, Hoppe T.

Nat Struct Mol Biol. 2016 Nov;23(11):995-1002. doi: 10.1038/nsmb.3296. Epub 2016 Sep 26.

2.

The tumour suppressor CYLD regulates the p53 DNA damage response.

Fernández-Majada V, Welz PS, Ermolaeva MA, Schell M, Adam A, Dietlein F, Komander D, Büttner R, Thomas RK, Schumacher B, Pasparakis M.

Nat Commun. 2016 Aug 26;7:12508. doi: 10.1038/ncomms12508.

3.

Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.

Eter N, Mohr A, Wachtlin J, Feltgen N, Shirlaw A, Leaback R; German Ozurdex in RVO Real World Study Group.

Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):77-87. doi: 10.1007/s00417-016-3431-x. Epub 2016 Jul 26. Erratum in: Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255 (1):89.

4.

The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.

de Zeeuw D, Bekker P, Henkel E, Hasslacher C, Gouni-Berthold I, Mehling H, Potarca A, Tesar V, Heerspink HJ, Schall TJ; CCX140-B Diabetic Nephropathy Study Group.

Lancet Diabetes Endocrinol. 2015 Sep;3(9):687-96. doi: 10.1016/S2213-8587(15)00261-2. Epub 2015 Aug 9.

PMID:
26268910
5.

[Pediatric palliative care: a national survey of French pediatric residents' knowledge, education, and clinical experience].

Lefeubvre C, Viallard ML, Schell M.

Arch Pediatr. 2014 Aug;21(8):834-44. doi: 10.1016/j.arcped.2014.05.012. Epub 2014 Jun 30. French.

PMID:
24993148
6.

Characterization of pilot-scale dilute acid pretreatment performance using deacetylated corn stover.

Shekiro Iii J, Kuhn EM, Nagle NJ, Tucker MP, Elander RT, Schell DJ.

Biotechnol Biofuels. 2014 Feb 18;7(1):23. doi: 10.1186/1754-6834-7-23.

7.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

8.

Experimental study on modulation of Stokes parameters on propagation of a Gaussian Schell model beam in free space.

Verma M, Senthilkumaran P, Joseph J, Kandpal HC.

Opt Express. 2013 Jul 1;21(13):15432-7. doi: 10.1364/OE.21.015432.

PMID:
23842331
9.

Regression of takayasu retinopathy after revascularization of occluded branches of the aortic arch by percutaneous angioplasty.

Peter J, Joseph G, David S, Danda D.

Retin Cases Brief Rep. 2013 Summer;7(3):262-6. doi: 10.1097/ICB.0b013e31828eef72.

PMID:
25391120
10.

Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization.

Pidala J, Kim J, Schell M, Lee SJ, Hillgruber R, Nye V, Ayala E, Alsina M, Betts B, Bookout R, Fernandez HF, Field T, Locke FL, Nishihori T, Ochoa JL, Perez L, Perkins J, Shapiro J, Tate C, Tomblyn M, Anasetti C.

Bone Marrow Transplant. 2013 Mar;48(3):346-50. doi: 10.1038/bmt.2012.150. Epub 2012 Aug 6.

11.

Ocular manifestations of Takayasu arteritis: a cross-sectional study.

Peter J, David S, Danda D, Peter JV, Horo S, Joseph G.

Retina. 2011 Jun;31(6):1170-8. doi: 10.1097/IAE.0b013e3181fe540b.

PMID:
21317836
12.

Hypoperfusive and hypertensive ocular manifestations in Takayasu arteritis.

Peter J, David S, Joseph G, Horo S, Danda D.

Clin Ophthalmol. 2010 Oct 21;4:1173-6. doi: 10.2147/OPTH.S12331.

13.

[The "do-not-resuscitate order" in paediatric palliative home care: why should the emergency team be involved ?].

Schell M, Marec-Bérard P, Glastre C, Langevin L, Frappaz D, Bergeron C, Joris ML, Castaing M, Devaux Y.

Bull Cancer. 2009 Sep 1;96 Suppl 2:29-35. doi: 10.1684/bdc.2009.0901. French.

PMID:
19903595
14.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.

Supplemental Content

Loading ...
Support Center